Abstract:Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are characterized by necrotizing inflammation of small and medium-size vessels that often manifest with devastating multi-organ effects. They present with a myriad of systemic features and require potent immunosuppression. Since they are uncommonly encountered in clinical practice, it is necessary to understand physicians' knowledge and perceptions about this group of diseases. An online questionnaire was designed featuring 28 questions based on relevant global practice guidelines, recommendations, and previous online surveys on AAV. The questionnaire was validated by a core group of specialists with an interest in AAV. It was shared via social networking sites and entries were restricted to physicians. Only completed entries were analyzed with descriptive statistics. A total of 113 respondents from 21 different countries responded of whom the commonest were rheumatologists, internists, and general practitioners. Forty-five (40%) ran clinics dedicated to AAV patients as a part of their practice. They commented on organs involved in AAV; vasculitis secondary to infections, drugs or other rheumatic diseases; various tests useful for AAV diagnosis; and drug choices for induction and maintenance. They mentioned their experience regarding COVID-19 in AAV patients as well as vasculitic manifestations of COVID-19. Various methods to mitigate cardiovascular risks in AAV were mentioned. Finally, the respondents indicated how medical education needed to be strengthened to increase awareness and knowledge regarding AAV. This survey helped to inform about various perceptions regarding AAV across countries, including current practices and recent evolution of management. It also provided information on treatment of the COVID-19 in AAV patients. This survey showed that there is still a lack in understanding the prevalent definitions and there is gap between guidelines and current practice. Key Points • Perception about ANCA-associated vasculitis differ across countries. • The number of cases encountered across 21 different countries are limited implying a need for multi-national cooperation to study this disease further. • The COVID-19 pandemic has changed the approach towards ANCA-associated vasculitis by the various clinicians.

The impact of coronavirus‐19 vaccination on anti‐nuclear cytoplasmic antibody vasculitis hospitalisations in a Sydney health network

New Insights of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis from the Perspective of COVID-19 Vaccination

ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review

ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine

ANCA-Positive Small-Vessel Vasculitis Following SARS-CoV-2 Vaccination—A Systematic Review

ANCA-associated Vasculitis Following the CoronaVac Vaccination

Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination

Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis

Association Between SARS-CoV-2 Vaccination and Development of Antinuclear Antibodies Among Students

De Novo Biopsy-Proven Glomerular Disease Following COVID-19 Vaccination

Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study

Flare and Change in Disease Activity among Patients with Stable Rheumatoid Arthritis Following Coronavirus Disease 2019 Vaccination: A Prospective Chinese Cohort Study.

Cardiovascular and cerebrovascular outcomes in anti-neutrophil cytoplasmic antibody-associated vasculitis: A systematic review with meta-analysis

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination

Autoimmune rheumatic diseases and COVID-19 vaccination: a retrospective cross-sectional study from Astana

Cardiovascular outcomes for people hospitalised with COVID‐19 in Australia, and the effect of vaccination: an observational cohort study

Physicians' perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic

Association of COVID‐19 Vaccinations with Flares of Systemic Rheumatic Disease: A Case‐Crossover Study

Otitis Media with ANCA-Associated Vasculitis Following COVID-19 mRNA Vaccination: A Case Report

Clinical phenotype of AAV, anti-GBM disease and double-positive patients after SARS-CoV-2 vaccination

A Population-Based Analysis of the Risk of Glomerular Disease Relapse after COVID-19 Vaccination